Journals / Bezm-i Alem Valide Sultan SSK Vakıf Gureba Eğitim Hastanesi Derg. / 2005 / Cilt: 3 - Sayı: 3

Intralesional steroid injection as treatment of chalazion

Şalazyon tedavisinde lezyon içi steroid enjeksiyonu

Pages
135–137
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No major complications occured.Conclusion: Intralesional injection of steroid appears to be a simple and effective treatment for chalazion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To study the effectiveness of intralesional steroid injection in the treatment of chalazion.
📊
Key Findings & Data:Study design: Prospective study Materials & Medhods: Patients with chalazion presenting to the out-patient clinic of the Eye Clinic of Vakif Gureba Education Hospital between November 2003 to January 2004 were included in the study.
💡
Conclusion & Impact:No major complications occured.Conclusion: Intralesional injection of steroid appears to be a simple and effective treatment for chalazion.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To study the effectiveness of intralesional steroid injection in the treatment of chalazion. Study design: Prospective study Materials & Medhods: Patients with chalazion presenting to the out-patient clinic of the Eye Clinic of Vakif Gureba Education Hospital between November 2003 to January 2004 were included in the study. Forty-six lesions of 36 patients were treated with intralesional injection of triamcinolone acetonide. Patients were followed up at days 1,7,15, and 30. In patients with no improvement a second injection was performed. Dissappereance of the lesion wasaccepted as success, and residual lesion as failure. Results: In the follow up 34 (73.9%) lesions improved in day 7. In 15 days 6 of the remaining 12 lesions improved with a total success rate of 87%. A secondary injection was performed to the remaining 6 (13%) lesions. Four of these lesions improved after secondary injection. After 30 days total success rate was found to be 95.6%. In 2 (4.6%) cases depigmentation at skin around the injection site and in 2 (4.6%) cases subcutaneous tissue atrophy was observed. No major complications occured.Conclusion: Intralesional injection of steroid appears to be a simple and effective treatment for chalazion.

Özet

Amaç: Þalazyon tedavisinde intralezyonel steroid uygulanmasının etkinliğinin değerlendirilmesi Çalışma düzeni: Prospektif çalışma Gereç ve Yöntem: Vakıf Gureba Hastanesi göz polikliniğine Kasım 2003 ve Ocak 2004 tarihleri arasında şalazyon şikayeti ile başvuran hastalar çalışmaya alındı. Otuzaltı hastada bulunan 46 lezyona, lezyon içine triamsinolon asetonid enjeksiyonu yapıldı. Hastaların 1, 7, 15, ve 30. günlerde takipleri yapıldı. Düzelme olmayan lezyonlara ikinci bir enjeksiyon yapıldı. Lezyonun kaybolması başarı, kayıp olmaması ise başarısızlık olarak kabul edildi. Bulgular: Takiplerde 34 (%73.9) lezyon ilk 7 günde düzeldi. Geriye kalan 12 lezyonun 6 sının %87'lik başarı oranı ile 15. günde düzeldiği gözlendi. Düzelmeyen 6 (13%) göze ikinci bir enjeksiyon yapıldı. Bu lezyonlardan 4'ü ikinci enjeksiyondan sonra düzeldi. Başarı 30. günde %95.6 idi. İki (%4.6) olguda enjeksiyon yeri çevresinde ciltte depigmentasyon ve iki olguda subkutan dokuda atrofi gözlendi. Önemli bir komplikasyon gözlenmedi. Sonuç: Lezyon içi steroid enjeksiyonu şalazyon tedavisinde etkili ve ucuz bir yöntem olarak gözükmektedir

🔖

Cite This Article

GÜLKILIK, G., ENGİN, G., TAŞKAPILI, M., ÖZSÜTÇÜ, M., KÜÇÜKŞAHİN, H., DURMAZ, Ş. (2022). Intralesional steroid injection as treatment of chalazion. Bezm-i Alem Valide Sultan SSK Vakıf Gureba Eğitim Hastanesi Derg., Cilt: 3 - Sayı: 3, 135–137. https://ajindex.com/articles/464173

References (1)

  1. Kanski JJ. Clinical ophthalmology. 4th ed. Boston: Butterworth-Heinemann; 1998. p.12-14 2. Gershen HJ. Chalazion. In: Fraunfelder FT, Roy FH, editors. Current ocular therapy. 2nd ed. Philedelphia: W.B. Saunders; 1985. p. 345-55 3. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology. 1980; 87:218-21 4. Watson AP, Austin DJ. Treatment of chalazions with injection of a steroid suspension. Br J Ophthalmol. 1984;68:833-5 5. Dua HS, Nilawar DV. Nonsurgical therapy of chalazion. Am J Ophthalmol. 1982;94:424-5 6. Cottrell DG, Bosanquet RC, Fawcett IM. Chalazions: the frequency of spontaneous resolution. Br Med J. 1983; 287: 1595 7. Bohigian GM. Chalazion: a clinical evaluation. Am Ophthalmol. 1979;11:1397-8 8. Kaufman HE, Barron BA, McDonald MB, Kaufman SC, editors. Companion handbook to the cornea. 2nd ed. Boston: Butterworth-Heinemann; 2000. p. 29-33 9. Ho SY, Lai JSM. Subcutaneous injection as treatment of chalazion: prospective case series. HKMJ. 2002;8:18-20 10. Marren SE, Bartlett JD, Melore GG. Diseases of the eyelids. In: Bartlett JD, Jaanus SD, editors. Clinical ocular pharmacology. 4th ed. Boston: Butterworth-Heinemann; 2001. p.485-522